Citius OncologyCTOR
13F holders, Q3 2025 (September 30)At the end of Q3 2025, 16 institutions reported holding Citius Oncology Inc. (CTOR) in their 13F filings, up 9 from Q2 2025. 10 opened new positions and 1 sold out. The largest holders were Armistice Capital, LLC ($15.6M), Vanguard Group Inc. ($366K) and Geode Capital Management, LLC ($339K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Citius Oncology Inc.
- CUSIP
- 17331Y109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $16.5M |
| Exits | 1 | $465K |
All 13F filers, Q2 2025 → Q3 2025: 8,260,312 shares bought and 130,645 shares sold, net +8,129,667 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Armistice Capital, LLC | 0.49% | New | 7,675,911 | $15.6M |
| Vanguard Group Inc. | 0.00% | New | 180,168 | $366K |
| Geode Capital Management, LLC | 0.00% | Add +191.8% | 167,172 | $339K |
| XTX Topco Ltd | 0.01% | New | 126,884 | $258K |
| Renaissance Technologies | 0.00% | New | 55,900 | $113K |
| State Street Corp. | 0.00% | New | 42,900 | $87K |
| IFP Advisors, Inc | 0.00% | Add +49.5% | 33,215 | $67K |
| Northern Trust Corp. | 0.00% | New | 21,764 | $44K |
| Citadel Advisors | 0.00% | New | 17,661 | $36K |
| Osaic Holdings, Inc. | 0.00% | Add +119.5% | 11,745 | $25K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 11,846 | $24K |
| Arkadios Wealth Advisors | 0.00% | No change | 11,666 | $24K |
| Bank of America Corp. | 0.00% | Reduce -96.9% | 264 | $536 |
| UBS Group AG | 0.00% | Reduce -99.6% | 55 | $112 |
| Morgan Stanley | 0.00% | New | 5 | $10 |
| Farther Finance Advisors, LLC | 0.00% | New | 3 | $6 |
"% of holder's portfolio" is CTOR's weight in each manager's 13F, not the share of Citius Oncology Inc. the manager owns.